Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients

CompletedOBSERVATIONAL
Enrollment

157

Participants

Timeline

Start Date

March 16, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Sickle Cell DiseaseThalassemiaPediatric Cancer
Interventions
BIOLOGICAL

Red Blood Cell (RBC) Transfusion

Simple RBC transfusion or partial manual exchange

Trial Locations (14)

10021

Weill Cornell Medical Collection (WCMC)/New York Presbyterian Hospital (NYPH), New York

10032

Columbia University Irving Medical Center/New York Presbyterian Hospital (NYPH), New York

10065

New York Blood Center (NYBC), New York

53226

Children's Wisconsin, Milwaukee

Froedtert Hospital, Milwaukee

53233

Versiti Wisconsin, Inc., Milwaukee

94118

Vitalant Research Institute, San Francisco

94609

UCSF Benioff Children's Hospital, Oakland

02115

Boston Children's Hospital, Boston

69050-001

HEMOAM - Amazonas, Manaus

30622-020

HEMOMINAS - Minas Gerais, Belo Horizonte

52011-000

HEMOPE - Pernambuco, Recife

20211-030

HEMORIO - Rio De Janeiro, Rio de Janeiro

05403-000

Childrens Institute and Adult Clinics at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Westat

OTHER